COMMONWEALTH EQUITY SERVICES, LLC - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 71 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q1 2020$46,000
-39.5%
10,0000.0%0.00%
Q4 2019$76,0000.0%10,0000.0%0.00%
Q3 2019$76,000
+11.8%
10,0000.0%0.00%
Q2 2019$68,00010,0000.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Yu Fan 112,044$50,4200.68%
Aisling Capital Management LP 1,691,151$761,0180.50%
Sio Capital Management, LLC 3,004,959$1,351,9310.50%
Bain Capital Life Sciences Investors, LLC 5,347,689$2,4060.27%
Ghost Tree Capital, LLC 800,000$360,0000.15%
Nantahala Capital Management 4,611,302$2,074,6250.13%
Samsara BioCapital, LLC 883,720$397,5860.09%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,059,894$1,826,5460.08%
SPHERA FUNDS MANAGEMENT LTD. 440,837$198,3330.04%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 245,678$1110.04%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders